During a live event, Tony Philip, MD, and participants discussed molecular profiling and active surveillance for desmoid ...

Plexiform fibromyxoma is a rare primary mesenchymal tumor of the gastrointestinal tract, first reported by Takahashi in 2007 and officially recognized as a subtype of gastric mesenchymal tumor by the ...

Dr. Breelyn Wilky discusses challenges that patients with GIST face and shares advice with those who feel overwhelmed by the ...

Breelyn Wilky, MD, discusses what key molecular insights in GIST management community oncologists should prioritize today.

Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses; however, molecular testing can help guides treatment decisions.

Testicular sex cord-stromal tumours (TSCSTs) are relatively rare, accounting for ~5% of all testicular neoplasms. They were historically classified into Leydig cell tumour, Sertoli cell tumour, ...

Gastrointestinal stromal tumors are among the first solid tumors for which cancer-(cell-)specific therapy became available. What is its pathogenesis, therapy strategies and drug resistance mechanisms?

The advances in the molecular understanding and development of target therapies have allowed a significant improvement in the prognosis of patients with advanced gastrointestinal stromal tumors.

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these ...

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these ...